In the rapidly evolving field of veterinary medicine, the development of new and more effective treatments hinges on the availability of high-quality chemical intermediates. Among these, fluorinated compounds and their derivatives play an increasingly significant role due to the unique properties fluorine imparts to molecules. One such critical intermediate is 1-(3,5-Dichloro-4-fluorophenyl)-2,2,2-trifluoroethanone (CAS: 1190865-44-1). This compound, often sought by R&D scientists and procurement managers, serves as a cornerstone in the synthesis of advanced veterinary drugs.

The significance of 1-(3,5-Dichloro-4-fluorophenyl)-2,2,2-trifluoroethanone lies in its specific chemical structure, which makes it an ideal precursor for complex active pharmaceutical ingredients (APIs). Notably, it is a key intermediate in the production of sarolaner, a widely used ectoparasiticide for dogs and cats. The high purity of this intermediate, typically exceeding 99%, is paramount for ensuring the efficacy and safety of the final veterinary product. Impurities can lead to reduced potency, unwanted side effects, or complex purification challenges, all of which are undesirable in pharmaceutical manufacturing.

When sourcing such specialized chemicals, procurement professionals look for reliability, consistent quality, and competitive pricing. Manufacturers based in China have become prominent global suppliers, offering a wide range of fine chemicals and intermediates. For businesses looking to buy 1-(3,5-Dichloro-4-fluorophenyl)-2,2,2-trifluoroethanone, identifying a reputable manufacturer that can guarantee continuous supply and adherence to strict quality standards is essential. Understanding the product's specifications, such as its physical appearance (white to light yellow solid), boiling point (228℃), and storage requirements (2-8°C), is crucial for effective handling and utilization.

The demand for innovative veterinary treatments continues to grow, driving the need for reliable suppliers of essential intermediates like this trifluoroethanone derivative. By partnering with experienced suppliers, pharmaceutical companies can streamline their research and development processes, accelerate product launches, and ultimately improve animal health outcomes worldwide. For those in need of this specific intermediate, exploring wholesale pricing and availability from trusted sources is the first step towards securing their supply chain.